[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKEDBYBRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. EXHIBIT 10.2 FIRST AMENDMENT TO SUPPLY AND MANUFACTURING AGREEMENT This First Amendment Holdings ("Amendment") to the Supply and Manufacturing Agreement dated April1, 2017 between Cerus Corporation Holdings ("Cerus") and Porex Corporation ("Porex") (the "Agreement") is made this 22 day of June 2018. RECITALSA. Cerus and Porex have agreed to make certain changes to the raw material and process to develop Components and such changes have resulted in a change to the cost and expense structure originally contemplated by the Agreement; B. Pursuant to Section 3 of the Agreement, Cerus and Porex have mutually agreed to temporarily modify the pricing for Platelet Wafers set forth on Exhibit D and to proactively set a cost structure for non-production related work. NOW THEREFORE Holdings, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the parties hereby agree to amend the Agreement as follows: 1. New Exhibits AA Holdings-1, AA-2, AA-3 and AA-4, as set forth in Schedule 1 to this Amendment, shall be attached to the Agreement (inserted between Exhibit A Holdings-5 and ExhibitB-1) and incorporated therein by reference. The parties acknowledge and agree that Exhibits AA-1, AA-2, AA-3 and AA-4 set forth the revised specifications for Platelet Wafers manufactured by Porex for Cerus (collectively, the "Revised Wafer Specifications"). Unless otherwise agreed in writing, Porex shall continue to manufacture and produce Platelet Wafers using the existing specifications for Platelet Wafers until Cerus gives written notice to Porex that Platelet Wafers shall be thereafter manufactured in accordance with the Revised Wafer Specifications. References in the Agreement to "Specifications" shall be interpreted to include the Revised Wafer Specifications, as applicable. 2. A new Exhibit D Holdings-1, as set forth in Schedule 2 to this Amendment, shall be attached to the Agreement and incorporated therein by reference. AsofApril1, 2018 and continuing until Cerus determines Holdings, in its sole discretion, that the ProtocolEPP-029-886 under which Porexiscurrentlyoperatingcanbediscontinued, the price for Platelet Wafers shall be the prices set forth in Exhibit D-1. UponCerus' determination that the Protocol EPP-029- 886 can be discontinued, CerusshallprovidewrittennoticethereoftoPorex, along with a new purchase order for Platelet Wafers (the "New Pricing PO"). On and after the date of such notice, the "Pricing" table for Platelet Wafers in Exhibit D, as of the date immediately preceding the date of this Amendment, shall be reinstated and apply to Platelet Wafers that are produced pursuant to the New Pricing PO and were also produced after the date of the written notice. References in Section 1.5.1 of the Agreement to "Exhibit D" shall be amended to include "Exhibit D-1," as applicable. 3. The penultimate sentence in Section 1.3 shall be deleted in its entirety and replaced with the following: "In no event shall any Purchase Order: require delivery of more than [*] units of [*] and [*] units of [*] in any [*] (the "Porex Capacity Limitations")." 4. AnewSection1.5.3 shall be added to the Agreement as follows:

1.5.3 Porex will invoice Cerus monthly for Services performed by Porex during the prior month. Unless otherwise expressly provided in the applicable Statement of Work payment to Porex of undisputed fees shall be due Holdings [*] days following Cerus' receipt of the invoice submitted by Porex. Payment information, including Tax Identification Number will be included on each invoice.

Cerus shall have the right to accept or reject the Services, or any portion thereof, in writing within [*] days from Porex's completion of the Services. Such acceptance or rejection shall be consistent with the criteria set forth in the Statement of Work, if any. If Cerus does not reject in writing within [*] days, the Services shall be considered accepted by Cerus. Within [*] days of any notice of rejection, Porex shall present a corrective plan of action to Cerus. UponapprovalbyCerusofthecorrectiveplan, Porex, at no additional expense to Cerus, shall then make the corrections and, where applicable, PorexshallresubmitthecorrectedServicestoCerus. For disputed invoices or the disputed portion of an invoice, Cerus shall use reasonable efforts to provide to Porex Holdings, in writing, within [*] days, a description of the disputed amounts. Cerus and Porex shall negotiate in a timely, good faith manner to resolve billing queries. Ceruswillnothaveresponsibilitytopayforidentifiederrors, incomplete or inaccurate items (collectively the "invoice errors") which result in increases to previously invoiced amounts if the aforementioned invoice errors are communicated to Cerus later than [*] days from the original invoice date.

5. A new Section 3a shall be added to the Agreement as follows: "3a Non-ProductionRelatedWork. From time to time, Cerus may submit to Porex written work orders substantially in the form of Schedule 3 that specify development activities, engineering analysis, part, material and/or fixture design and development, or other services or activities that Cerus requests Porex to perform that are not activities or services that are necessary for the then Holdings-current manufacture and production of Components for Cerus under the Agreement Holdings (collectively, as defined in each work order, the "Services"). Each work order shall set forth the terms and conditions (including specifications (if applicable), delivery and performance schedules, and fees) pursuant to which Porex will perform the Services. Upon acceptance of a work order by Porex (in writing), such work order shall become a "Statement of Work." IfPorexbeginstoperformservicesunderaworkorderthathasnotbeenformallyagreedinwriting, then Porex shall bear the costs of any expenses incurred prior to formal written agreement of the Statement of Work. Cerus hereby consents to Porex's use of the Cerus Dedicated Space and Equipment, as specified in a Statement of Work, solely as necessary to perform the Services under that Statement of Work. SuchconsentshallautomaticallyterminateuponthecompletionoftheapplicableStatementofWorkandislimitedbythetermsoftheAgreement. IntheeventofanyconflictbetweentheAgreementandaStatementofWork, the Agreement shall control unless the Statement of Work expressly refers to the Parties Holdings' intent to alter the terms of the Agreement with respect to that Statement of Work and shall not be construed as an amendment to the terms of the Agreement." 6. A new section titled "Pricing for Non-Production Related Work Orders from Cerus" is added to ExhibitDassetforthinSchedule2 attached. Such pricing, upon mutual agreement of the Parties, shall apply to any Statement of Work mutually agreed by the Parties pursuant to Section 3a. 7. No other changes are made to the Agreement, including without limitation, the original Exhibit D, and the Agreement, the Plasma Disk pricing and related information as set forth in Exhibit D remain the same Holdings. Except as amended herein Holdings, the Agreement shall remain in full force and effect. CapitalizedtermsnototherwisedefinedhereinshallhavethesamemeaningsassetforthintheAgreement. IN WITNESS WHEREOF, the undersigned have caused this FirstAmendmenttobesigned, all as of the date first written above.

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Porex: Porex Corporation By: /s/ Tore Wistedt Name: Tore Wistedt Title: SR VP Global Strategy Marketing

Cerus: Cerus Corporation By: /s/ Kevin D. Green Name: Kevin D. Green Title: VP Finance and CFO Holdings

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Exhibit AA-2 SPC 00628 {3 pages omitted}

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Exhibit AA-3 SPC 00628A {3 pages omitted}

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Schedule 2 Exhibit D-1 Pricing [*] Pricing [*]

SCHEDULE  Holdings3

[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

The term of this Statement of Work will begin on ___________ and shall terminate on ____________.

Cerus Corporation

Signed: Name: Title: Dated:

Porex Corporation

Signed: Name: Title: Dated: